bpc-157 fda news today 🚨 HUGE FOR 🚨 Today, the FDA's Pharmacy Compounding Advisory Committee voted 8–6, with 1 abstention, in favor of recommending BPC-157 for inclusion on the 503A Bulk Drug Substances List BREAKING NEWS: The FDA advisory

In addition to providing long-term weight loss and possibly remission of T2DM, bariatric surgery is not feasible for large populations, has specific indications, and may result in surgical complications as well as other issues like malabsorption and micronutrient deficiencies

Each peptide vial used for reconstitution must be labeled For Research Use Only, ensuring it is not administered to patients or individuals outside controlled laboratory studies

Yiallouris A, Tsioutis C, Agapidaki E, Zafeiri M, Agouridis AP, Ntourakis D, Johnson EO

I would like to see rigorous clinical trials before approval

Traditional treatments are more widely available and some countries have subsidies, so theyre more accessible to the majority